medicines for europe AISBL
18.0 FTEmedicines for europe reported total assets of €3.68m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Jul 2026), with 18 full-time equivalents.
By total assets for 2025, medicines for europe ranks among the 20 largest of the 169 companies in its sector (NACE 9412) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of medicines for europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -16 % Total assets +1 % Headcount (avg FTE) +38 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
medicines for europe's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 31 Jul 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 24 Jun 2024
- Year ended 31 Dec 2022filed on 26 Jun 2023
- Year ended 31 Dec 2021filed on 13 Jul 2022
medicines for europe's financial analysis
- Solvency68.6%sector median: 68.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of medicines for europe
16 active director(s) in the register.
and 10 more
medicines for europe's shareholders and holdings →medicines for europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0449.332.209
- VAT number
- BE0449332209
- Peppol
- Registered · 0208:0449332209 · as of 10 Nov 2026
- Legal form
- AISBL
- Incorporated
- 26 Oct 1992
- Registered office
- 1050 Ixelles
- Size
- Small · 18.0 FTE
- Latest accounts
- 2025 · filed on 31 Jul 2026
- Activity
- Activities of professional membership organisations (NACE 94120)
medicines for europe (AISBL) has been based in Ixelles since 1992, active in: activities of professional membership organisations. For 2025, it reports a net loss of 972,902 € and equity of €2.52m; its revenue is not published. With 18.0 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 68.6%, above the median of its sector (68.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to medicines for europe
Companies in the same business, of comparable size and area, outside its group.
- Netwerk Verpleegkunde Activities of professional membership organisations Schaerbeek · balance sheet €2.96m
- pharmacy.brussels Activities of professional membership organisations Evere · balance sheet €2.91m
- Impact Europe Activities of professional membership organisations Brussels · balance sheet €3.31m
- Belgisch Centrum voor Farmacotherapeutische Informatie-Centre Belge d'Information Pharmacothérapeutique Activities of professional membership organisations Saint-Josse-ten-Noode · balance sheet €2.33m
- European Association of Research Managers and Administrators Activities of professional membership organisations Brussels · balance sheet €2.08m
- Conseil des Notariats de l'Union Europeenne Activities of professional membership organisations Brussels · balance sheet €1.85m
- Detergents Europe Activities of business and employers membership organisations Auderghem · balance sheet €4.08m
- Comité des Associations d'Armateurs des Communautés européennes Activities of business and employers membership organisations Brussels · balance sheet €3.18m
Frequently asked questions about medicines for europe
What is the revenue of medicines for europe?
medicines for europe files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of medicines for europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0449332209 for medicines for europe, if the company is VAT-registered. Its company number (CBE) is 0449.332.209.
Where is the registered office of medicines for europe?
According to the CBE register, the registered office of medicines for europe is in 1050 Ixelles.
What is the equity of medicines for europe?
At the close of the 2025 financial year, the equity of medicines for europe amounts to 2,522,483 €, a solvency of 68.6% of total assets.
How many people work at medicines for europe?
18.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages medicines for europe?
The register lists 16 active mandates at medicines for europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is medicines for europe within its sector?
By total assets for 2025, medicines for europe ranks among the 20 largest of the 169 companies in its sector (NACE 9412) in Belgium that filed accounts for that financial year.
The full file of medicines for europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →